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ABSTRACT
 دقو لافطلاا يف ادج ةردانلا تلاالحا نم ربتعي يسفنتلا زاهلجا فيزن
 رمعلا  نم  غلبت  ةلفط  ةلاح  شقاننس  ريرقتلا  اذه  يف  .ةافولل  يدؤي
 تاريعشلا باهتلا نم تجان ةئرلا يف رركتم فيزن نم يناعت ماع 11
 هذه ىمستو .نلآا ىلإ ببس اهل ددحي مل يتلاو ةئرلا لخاد ةيومدلا
 تناكو  .ببسلا  لوهجم  يبلسلا  يوئرلا  تاريعشلا  باهتلا  :ةلالحا
 ةعانملل ةضفاخ ىرخأ ةيودأو ينلوزينديربلا جلاع مدختست ةضيرلما
 تناكو يراوطلا مسقل ترضح ةلفطلا .فيزنلا تابون نم ليلقتلل
 .ىرسيلا ردصلا ةهج يف ملأو ينجسكلأا يف داح صقن نم يناعت
 ةطلج دوجو ينبت ردصلل ةيعطقلما ةعشلأاو تاصوحفلا لمع دعبو
 ةردانلا  ضارملأا  نم  ةلالحا  هذه  دعتو  .رسيلأا  يوئرلا  نايرشلا  يف
 نوكت  دق  نكلو  دعب  ةطللجا  ببس  ددحي  مل  .لافطلأا  يف  ًادج
 ةكرلحا مدعو ،ةنمسلا  ببسب طلجتلل  ةيلباقلا  اهدنع ةضيرلما  ةلاح
  .نوزيتروكلا ءاودل نمزلما مادختسلااو
Diffuse alveolar hemorrhage is an uncommon and often 
fatal condition in children that is characterized by distinct 
histopathological etiologies. Herein, we discuss the case of 
an 11-year-old girl who presented with acute worsening 
of hypoxia and left-sided chest pain. The patient had 
lung biopsy-proven idiopathic pulmonary capillaritis 
and was being treated with prednisolone every alternate 
day, azathioprine, and hydroxychloroquine. A contrast-
computed tomography (CT) scan of the chest showed 
an acute left lower-lobe pulmonary embolism. Negative 
results were obtained on a test for thrombophilia. In 
children, pulmonary embolism with anti-neutrophil 
cytoplasmic antibody-negative idiopathic pulmonary 
capillaritis is a rare clinical condition. The exact cause of 
thrombus formation in this case is unknown; however, 
obesity, immobility, and chronic systemic corticosteroid 
therapy probably played a role.
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Diffuse alveolar hemorrhage (DAH) is an uncommon condition caused by a variety of 
disorders.1,2 A DAH event can be life-threatening; 
therefore, timely intervention is critical. The DAH 
can mimic infectious and non-infectious disorders of 
the lower respiratory tract, such as chronic bacterial 
and fungal lung infections; pulmonary edema, chronic 
aspiration syndrome, and hypersensitivity pneumonitis. 
The diagnosis of DAH is often delayed due to the rarity 
of hemoptysis as a presenting symptom of DAH in 
children.1 Common respiratory symptoms in children 
with DAH include cough, dyspnea, and hypoxia. 
Radiographic abnormalities (alveolar or mixed alveolar/
interstitial patterns) are also common; however, such 
findings are non-specific. The DAH can occur as part 
of a systemic disease or as an isolated lung pathology. 
Isolated DAH lung pathologies have recently been 
classified as DAH with and without capillaritis.1 Isolated 
capillaritis is characterized by inflammatory disruption 
of the capillary network, which leads to leakage of 
blood into the alveoli and interstitium.1,2 Idiopathic 
pulmonary capillaritis (IPC) is associated with high 
mortality and morbidity due to recurrent DAH, which 
is usually resistant to treatment. Autoimmune and 
vasculitic disorders can present with DAH caused by 
pulmonary capillaritis.1,3 Although, anti-neutrophil 
cytoplasmic antibody (ANCA)-associated vasculitis is 
considered a hypercoagulable disorder associated with 
an increased risk of thromboembolic events,4 there have 
been no reports on the risk of thrombosis in children 
with ANCA-negative capillaritis. In this report, we 
have described a rare case of ANCA-negative IPC 
complicated by acute pulmonary embolism. 
Case Report. An 11-year-old girl with recurrent 
DAH presented with worsening hypoxia and left-sided 
chest pain. The patient was first admitted at 8 years 
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of age due to a sudden episode of pallor and jaundice 
(Table 1). A physical examination revealed that the child 
was well-nourished and had significant pallor and mild 
jaundice. Neither respiratory distress, nor organomegaly 
were observed. Verbal consent was obtained from the 
patient’s family and documented in her medical chart 
before the creation of this report.
Clinical findings. At first hospital admission, the 
laboratory findings were as follows: hemoglobin (Hb) 
level 3.6 g/dL (reference range [RR], 11.5-15.5 g/
dL), mean corpuscular volume 69.4 fL (RR, 77.0-95.0 
fL), mean corpuscular hemoglobin level 19.6 pg (RR, 
25.0-33.0 pg), and reticulocyte count 9.65% (reference 
level, <2%). Her white blood cell count and platelet 
count were within normal limits. A blood smear showed 
moderate anisopoikilocytosis with polychromasia. Her 
serum lactate dehydrogenase level was elevated to 887 
IU/L (RR, 125-243 IU/L), and her haptoglobin level 
was normal (35 mg/dL; RR, 11-220 mg/dL). A direct 
Coombs test revealed negative results. Her serum 
ferritin level was 71 ng/mL (RR, 9-185 ng/mL), and 
her iron and transferrin values were normal. However, 
the transferrin saturation was borderline low. Extensive 
testing to determine the underlying cause of anemia 
revealed normal findings; she underwent an upper 
endoscopy and tests to detect anti-gliadin and tissue 
transglutaminase antibodies, which are indicators of 
celiac disease; the results were all negative. She received 
a blood transfusion due to symptomatic anemia, and 
oral iron supplement therapy was started given her 
borderline low transferrin saturation. Table 1 provides a 
timeline of the patient’s care.
Diagnostic assessment. Four months after the 
first hospital admission, she was admitted with fever, 
cough, and hypoxia. A nasopharyngeal swab was 
positive by real-time PCR for respiratory syncytial 
virus and influenza. A chest X-ray (CXR) revealed 
multifocal air-space disease consistent with pneumonia. 
Her Hb level was 9.6 g/dL. The patient received 
intravenous antibiotics and supplemental oxygen and 
was discharged on 1 L/min night-time oxygen due 
to frequent night-time hypoxia. Tests for primary 
immunodeficiency and human immunodeficiency virus 
were negative. 
She continued to have frequent episodes of 
respiratory insufficiency and anemia with persistent 
CXR opacities involving the upper lobes. A CT scan 
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of the chest showed diffuse airspace disease of both 
lungs that was most pronounced in the upper lobes. 
The chronic anemia, recurrent respiratory illnesses, 
and bilateral lung opacities suggested recurrent alveolar 
hemorrhages. Flexible bronchoscopy and open lung 
biopsy were performed. Bronchoalveolar lavage of 
the right middle lobe showed blood-stained fluid and 
yielded abundant hemosiderin-laden macrophages. 
A lung biopsy revealed a recent alveolar hemorrhage 
as well as signs of chronic changes most likely due to 
previous bleeding episodes. The signs of chronic changes 
included abundant hemosiderin-laden macrophages 
in the interstitium and alveolar spaces, and iron 
encrustation of vascular structures. No evidence of 
active vasculitis or capillaritis was observed (Figure 1). 
An autoantibody panel revealed negative results for 
anti-glomerular basement membrane antibodies, 
rheumatoid factors, ANCAs, anti-nuclear antibodies, 
proteinase-3 antibodies, anti-cardiolipin IgG antibodies, 
beta-2 glycoprotein antibodies, anti-Smith antibodies, 
and anti-dsDNA antibodies. These findings supported a 
diagnosis of idiopathic pulmonary hemosiderosis.
Therapeutic intervention. The patient was admitted 
and treated with a methylprednisolone pulse dose for 3 
days. Treatment was continued with a low dose of oral 
prednisolone. Under this course of treatment, frequent 
acute alveolar hemorrhages occurred; she was therefore 
transitioned to a regular steroid treatment with 10-20 
mg of prednisolone every alternate day in addition to 
azathioprine and hydroxychloroquine. 
When the patient was 10 years of age, she presented 
with worsening hypoxia and left-sided chest pain. She 
had no fever, hemoptysis, leg pain, or swelling. An 
examination revealed tachypnea, retractions, and an 
oxygen saturation of 94% on nasal cannulation at 5 
L/min. Chest auscultation revealed decreased breath 
sounds at the base of the lungs and inspiratory crackles. 
Her Hb level was 13.3 g/dL, and her hematocrit level 
was 39.8%. A CXR revealed bilateral reticular opacities 
that were markedly improved from those observed 
in the previous CXR, which was obtained prior to 
discharge, when she had the last episode of DAH 3 
months before this presentation. A chest CT showed 
an acute left lower lobe pulmonary embolism and 
bilateral patchy airspace disease (Figure 2). A Doppler 
ultrasound of the lower limbs showed no evidence of 
deep vein thrombosis (data not shown). The results 
of a thrombophilia test to measure C and S proteins, 
antithrombin III, prothrombin gene mutations, and 
factor V Leiden were negative. The patient was started 
on low-molecular-weight heparin (enoxaparin sodium) 
at 1 mg/kg twice a day with frequent monitoring of 
anti-Xa levels which was later stopped after 6 months as 
per hematologist recommendations. 
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threatening hypoxic respiratory failure due to DAH 
despite compliance to treatment. Histopathological 
findings were frequently reviewed to confirm the 
diagnosis. 
The exact cause of thrombus formation in 
ANCA-negative IPC is unknown; however, obesity, 
immobility, and chronic systemic corticosteroid therapy 
probably played a role in this patient’s condition. 
Thromboembolism has been documented in numerous 
types of small blood vessel vasculitis, including 
granulomatosis with polyangiitis, eosinophilic 
granulomatosis with polyangiitis, and microscopic 
polyangiitis.4 
The IPC is a rare etiology of alveolar hemorrhage1,2 
in childhood. It has 2 common presentations: severe 
life-threatening DAH and chronic anemia, the latter 
of which is often the result of iron deficiency and 
causes chronic persistent respiratory symptoms.5 Our 
patient experienced chronic progressive respiratory 
symptoms with frequent alveolar hemorrhages, mainly 
triggered by acute viral illness. The IPC is diagnosed 
by histopathological observation of erythrocytes leaking 
into the interstitium, fibrinoid necrosis of the capillary 
walls, and intra-alveolar septal capillary occlusion 
by fibrin thrombi.6 In acute intra-alveolar bleeding, 
Table 1 -  Timeline from the first presentation to final diagnosis.
 
Date Presentations Diagnostic tests Interventions
March 
2014
Pneumonia, acute 
hemolysis, and iron-
deficiency anemia
Chest X-ray showed diffuse airspace disease
Negative Direct Coomb’s test
Intravenous antibiotics and blood 
transfusion 
July- 
November 
2014
Recurrent pneumonia 
and acute hemolysis
Positive Indirect Coomb’s test
Parainfluenza and adenovirus real-time PCR positive on 
nasopharyngeal swab
Oral prednisolone 2 mg/kg/day for 5 days
February 
2015
Life-threatening 
hypoxic respiratory 
failure due to diffuse 
alveolar hemorrhage 
A computed tomography scan of the chest showed diffuse airspace 
disease in both lungs that was most pronounced in the upper lobes. 
Flexible bronchoscopy and open lung biopsy were performed. 
Bronchoalveolar lavage of the right middle lobe showed blood-stained 
fluid and yielded abundant hemosiderin-laden macrophages. A lung 
biopsy revealed a recent alveolar hemorrhage as well as signs of chronic 
changes most likely due to previous bleeding episodes. The signs of 
chronic changes included abundant hemosiderin-laden macrophages in 
the interstitium and alveolar spaces and iron encrustation of vascular 
structures. No evidence of active vasculitis or capillaritis was observed. 
She was treated with a methylprednisolone 
pulse dose for 3 days, then continued a 
low dose of oral prednisolone. Under this 
course of treatment, she suffered frequent 
acute alveolar hemorrhages; she was 
therefore transitioned to a regular pulse 
steroid with 10-20 mg of prednisolone 
every other day in addition to azathioprine 
and hydroxychloroquine.
March 
2016 
Worsening hypoxia 
and left-sided chest 
pain
A computed tomography scan of the chest showed an acute left 
lower-lobe pulmonary embolism and bilateral patchy airspace disease. 
The results of a thrombophilia test to measure C and S proteins, 
antithrombin III, prothrombin gene mutations, and factor V Leiden 
were negative.
The patient was started on low molecular 
weight heparin (enoxaparin sodium 
at 1 mg/kg twice a day) with frequent 
monitoring of anti-Xa levels. 
March 
2017 
Frequent life-
threatening hypoxic 
respiratory failure 
due to diffuse alveolar 
hemorrhage 
A biopsy sample was reviewed at the Childhood Interstitial Lung 
Diseases Center, and neutrophilic infiltration of the alveoli and 
interstitium was observed. Therefore, a diagnosis of idiopathic 
pulmonary capillaritis was established. 
Induction therapy with rituximab and 
monthly intravenous immunoglobulin was 
started. 
Since August 2017, the patient has been stable on 2 L/min oxygen via nasal cannula with very mild episodes of alveolar hemorrhages. She received 
monthly rituximab for 3 months and is now receiving azathioprine, hydroxychloroquine, and monthly intravenous immunoglobulin therapy 
Follow-up and outcome. The patient continued 
to have frequent alveolar hemorrhages despite 
prednisolone administration every other day as 
well as daily hydroxychloroquine and azathioprine 
administration. A lung biopsy sample was reviewed at 
another Childhood Interstitial Lung Diseases (chILD) 
Center, and neutrophilic infiltration of the alveoli 
and interstitium were observed. Therefore, a diagnosis 
of IPC was established, and induction therapy with 
rituximab and monthly intravenous immunoglobulin 
was started. Since August 2017, the patient has been 
stable on 2 L/min oxygen via nasal cannula with very 
mild episodes of alveolar hemorrhages. She received 
monthly rituximab for 3 months and is now receiving 
azathioprine, hydroxychloroquine, and monthly 
intravenous immunoglobulin therapy. 
Discussion. This case reveals 2 clinical challenges 
of DAH due to pulmonary capillaritis in children: 
1) it is rare and challenging to diagnose; and 2) if it 
is complicated by thromboembolism, treatment is 
difficult. The patient in the reported case was initially 
diagnosed with idiopathic pulmonary hemosiderosis 
and had received treatment for 2 years without any 
improvement. She had continued episodes of life-
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erythrocytes fill the alveolar space and disrupt gas 
exchange. In contrast, in chronic bleeding, macrophages 
engulf erythrocytes, causing hemosiderin deposition.7 
No known etiology clearly explains the alveolar and 
capillary network destruction and thromboembolic 
events that occur in this disease. Various pathways 
have been shown to be involved in the underlying 
pathobiological defects of thromboembolism in ANCA-
associated vasculitic disorders.4 Interactions between 
activated neutrophils and endothelial cells lead to 
massive endothelial damage and thrombus formation4 
In addition, electron microscopic studies have shown 
that immune complex-mediated processes may be active, 
even in the absence of immune deposition.4 Studies in 
adults have shown that anti-endothelial antibodies play 
a role in the pathogenesis of isolated ANCA-negative 
pulmonary capillaritis.4 
Pulmonary thromboembolism was previously 
reported in a child with ANCA-positive pulmonary 
capillaritis.6 There are some reports of similar cases in 
adults;7 however, there are no other reports regarding 
children with ANCA-negative IPC who presented 
with an acute pulmonary embolism. Our patient had 
no evidence of systemic involvement, and all tests for 
connective tissue disorders yielded negative results. 
Immunosuppressive therapy is considered the main 
treatment for this condition and pulse steroids are 
often needed in case of acute life-threatening bleeding. 
However, in case of the occurrence of a thrombus, 
anticoagulants should also be administered to alleviate 
the risk of further thrombus formation. 
In conclusion, treatment of a thrombus in patients 
with recurrent alveolar bleeding is challenging, and 
the condition may have life-threatening consequences. 
Anticoagulation therapy should be monitored closely 
and ceased in the presence of any early signs of acute 
pulmonary hemorrhage. For IPC patients, regular 
follow-up is crucial to allow early identification of new 
organ involvement. Further pathobiological studies are 
needed to clearly identify the exact pathology underlying 
this association and to propose treatment options. 
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Figure 2 - Left pulmonary artery embolism (black arrow).
Figure 1 - Numerous red blood cells in the alveolar space and abundant 
hemosiderin-laden macrophages in the interstitium and 
alveolar spaces (*). A lymphoid follicle is present in the center 
of the image (arrow).
